Venture firm Andreessen Horowitz has co-led a $200 million investment in Genesis Therapeutics, a biotechnology startup that harnesses the power of artificial intelligence (AI) to discover medicines for molecular targets that have posed challenges to the pharmaceutical industry. Genesis Therapeutics has developed a unique AI platform that analyzes intricate datasets to identify potential therapeutic molecules […]
– Venture firm Andreessen Horowitz Co-leads $200M Investment in Genesis Therapeutics – NNN – NNN – Latest News Updates Today…
Read More
